White matter damage and dementia markers in normal pressure hydrocephalus
Official title: Observational Study to Investigate the Effect of White Matter Tract Distortion and Neurodegenerative Biomarkers on Shunt-responsiveness in Idiopathic Normal Pressure Hydrocephalus (iNPH)
Run by Imperial College London · NCT07103681 · Data updated 2026-11-12
This study tries to see if patterns of white matter damage, dementia-related biomarkers, wearable activity monitors, and digital cognitive tests can predict and track which older adults with normal pressure hydrocephalus will improve after CSF shunt surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Imperial College London Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | March 25, 2025 |
| Main results expected | February 2028 |
| Study ends | February 2029 |
| Registry record updated | March 27, 2026 |
| Trial ID | NCT07103681 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 60 with symptomatic communicating normal pressure hydrocephalus (not secondary causes), particularly those with gait difficulty and who can tolerate MRI and lumbar puncture and are suitable candidates for possible shunt surgery.
✕Probably not a fit
People who are asymptomatic, have secondary or high‑pressure hydrocephalus, have a clear alternative explanation for symptoms (for example advanced Parkinson's disease), are too frail or medically unstable for surgery, or cannot undergo MRI or lumbar puncture are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center observational cohort will follow about 50 symptomatic adults with idiopathic or late-presenting communicating normal pressure hydrocephalus through initial assessment and, if performed, CSF shunt surgery, with two control groups of 50 asymptomatic chronic-hydrocephalus and 50 non-hydrocephalus participants. Participants undergo detailed gait, cognitive, urinary, and quality-of-life testing alongside diffusion MRI, blood and CSF biomarker sampling, and optional brain and skin biopsies. The study will also test the acceptability and data value of wearable activity and bed-sleep monitors and self-administered digital cognitive assessments before and after surgery. Clinical, imaging, and biomarker data will be stored in REDCap and analyzed to compare changes in shunt responders versus non-responders, with shunt response defined by gait speed improvement.
Why it matters
Potential benefit: If successful, this work could help doctors predict who is likely to benefit from CSF shunting and provide objective ways to monitor recovery using biomarkers and wearable/digital measures.
How similar studies have gone: Prior small studies have identified some imaging and CSF biomarker patterns linked to shunt response but results are mixed, and the use of wearables and self‑administered digital cognitive testing in NPH is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Group 1 (communicating hydrocephalus): Inclusion Criteria: * Adult patients \>60 * With gait apraxia * With or without cognitive impairment * Urinary dysfunction * Communicating Hydrocephalus Exclusion Criteria: * Asymptomatic hydrocephalus * High pressure-hydrocephalus * Serious head injury within 5 years of presentation or a clear secondary cause (e.g. brain infection) * History of childhood gait disturbance * Clear alternative explanation for symptoms (e.g. Parkinson's disease with limb rigidity, peripheral neuropathy with sensory ataxia, cervical myelopathy). * Too frail for shunt surgery * Medically unstable (e.g. active angina, respiratory disease, recurrent delirium, active epilepsy). * Unable to tolerate MRI brain imaging * Unable to have a lumbar puncture * Immobile * Unable to attend the hospital for study visits Group 2 (asymptomatic and non-hydrocepahlus dementia and healthy controls): Inclusion Criteria (Any of the following): * Healthy Carers * Members of the Public * Staff of Imperial College/ICHT * Non-NPH Dementias (including Alzheimer's disease or vascular dementia) * Asymptomatic Hydrocephalus Exclusion Criteria: \- Unable to attend the hospital for study visits
Where it's running
-
Imperial College Healthcare NHS Trust
London, United Kingdom Recruiting
Study contacts
- Study coordinator: Chris Carswell
- Email: NPH@imperial.ac.uk
- Phone: +44 20311 1234
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CSF Flow MRI to aid diagnosis and prognosis in normal pressure hydrocephalus
We’re testing if MRI measurements of CSF flow can help diagnose normal pressure hydrocephalus and predict how patients will respond to CSF drainage.
-
Evaluating outcomes in neurosurgery using standardized measures
This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.
-
Evaluating gait changes in patients with normal pressure hydrocephalus using smart insoles
This study is testing if a CSF tap can improve walking and balance in people with normal pressure hydrocephalus by using smart insoles to track their movements.
-
Comparing protein patterns in skin biopsies of neurodegenerative diseases
This study is trying to see if the patterns of certain proteins in skin samples can help doctors better understand and diagnose different neurodegenerative diseases like Alzheimer's, Parkinson's, and frontotemporal dementia.
-
Investigating early signs of Normal Pressure Hydrocephalus
This study is trying to see if special brain scans and tests on spinal fluid and blood can help predict how Normal Pressure Hydrocephalus develops in people who have early signs, those with symptoms, and healthy individuals over five years.
-
Sleep apnea and how it affects shunts in normal-pressure hydrocephalus
This project will measure intracranial and intra-abdominal pressures during sleep in people with normal-pressure hydrocephalus to see if sleep apnea affects shunt function and whether treating sleep apnea improves symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.